Advisors Preferred, LLC Zoetis Inc. Transaction History

Advisors Preferred, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$155.97 - $200.09 $404,118 - $518,433	-2,591 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$181.39 - $234.03 $469,981 - $606,371	2,591 New	2,591 $495,000
Q4 2021 Feb 07, 2022	SELL	$193.69 - $247.03 $1.55 Million - $1.98 Million	-8,018 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$189.29 - $209.69 $1.52 Million - $1.68 Million	8,018 New	8,018 $1.57 Million
Q1 2020 Apr 20, 2020	SELL	$92.66 - $144.94 $91,640 - $143,345	-989 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$116.25 - $133.25 $114,971 - $131,784	989 New	989 $131,000
Q2 2018 Aug 07, 2018	SELL	$79.9 - $89.2 $15,340 - $17,126	-192 Closed	0 $0
Q1 2018 Apr 30, 2018	SELL	$71.51 - $84.69 $3,074 - $3,641	-43 Reduced 18.3%	192 $16,000
Q4 2017 Feb 12, 2018	SELL	$63.24 - $72.8 $46,165 - $53,144	-730 Reduced 75.65%	235 $17,000
Q3 2017 Oct 31, 2017	BUY	$59.73 - $65.4 $57,639 - $63,111	965	965 $62,000

1,957

410M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $76.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.